Choose Your Country or Region

Tafasitamab (Anti-CD19)

Synonyms: XmAb5574; MOR00208; Tafasitamab-cxix

Catalog No.A2563 Purity: 99%

Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.

Tafasitamab (Anti-CD19)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 10.3mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.

Product Details

CAS No.	1422527-84-1
Molecular Weight	144.56 kDa
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Tags: buy Tafasitamab (Anti-CD19) | Tafasitamab (Anti-CD19) supplier | purchase Tafasitamab (Anti-CD19) | Tafasitamab (Anti-CD19) cost | Tafasitamab (Anti-CD19) manufacturer | order Tafasitamab (Anti-CD19) | Tafasitamab (Anti-CD19) distributor

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID